-
This Botox Rival Just Hit The Stratosphere — Here's Why
17 Jan 2025 16:19 GMT
… the inclusion of Linzess, which Ironwood Pharmaceuticals (IRWD) co-markets with AbbVie … To Buy And Watch: Top IPOs, Big And Small Caps, Growth …
-
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
04 Nov 2021 12:37 GMT
… Approval, Kidney Conference, More IPOs In The Pipeline
Chimerix Sinks … : LNTH) (before the market open)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (before …
IPOs
Hamburg, Germany-based Evotec SE (NASDAQ: EVO) priced its downsized initial public offering …
-
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
31 Oct 2021 19:30 GMT
… LNTH) (before the market open)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) ( … before the market open)
IPO Calendar
IPO Pricing
Hamburg, Germany-based … a 22-million ADS initial public offering at a price of … "NVCT."
IPO Quiet Period Expiry
Theseus …
-
Sarissa Capital Issues Statement On Ironwood Pharmaceuticals
31 May 2018 14:21 GMT
… made the following statement regarding Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD).
We believe … capitalize the other or an IPO of 20% of one of …
-
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
30 Jul 2021 12:43 GMT
… to its second-quarter results)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) … (before the market open)
IPOs
Immuneering Corporation (NASDAQ: IMRX), … dynamics, priced its upsized initial public offering of 7.5 million … , priced its upsized IPO of 13.5 million …
-
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
29 Jul 2021 12:56 GMT
… Public Limited Company (NASDAQ: HZNP)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
… Systems (after the close)
IPOs
Nuvalent, Inc., (NASDAQ: NUVL … in cancer, priced its initial public offering of 9.75 million … diseases, priced its upsized IPO of 12.13 million …
-
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
24 Jun 2021 12:44 GMT
… , Inc. (NASDAQ: ISRG)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
Lantheus … Presentations And 4 IPOs
Applied Genetic Reports Positive … AEMD) (after the close)
IPO
Monte Rosa Therapeutics, Inc., … proteins, priced its initial public offering of 11.7 million …
-
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-term Migraine Drug Data, Decision Day For Eton, 2 IPOs
27 May 2021 12:30 GMT
… Of Irritable Bowel Syndrome Treatment
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD … ASND) (after the close)
IPOs
Day One Biopharmaceuticals, Inc., … cancers, priced its initial public offering of 10 million shares … , priced its upsized IPO of 10.2 million …
-
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
06 Aug 2020 12:14 GMT
… : TXMD) (before the market open)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (before the … (NASDAQ: NKTR) (after the close)
IPOs
Acutus Medical, Inc., an arrhythmia … diagnosed and treated, priced its initial public offering of 8.824 million shares …
-
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
13 Feb 2020 13:22 GMT
… : KPTI) (before the market open)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (before the … . (NYSE: BIO) (after the close)
IPOs
Revolution Medicines, a biotech developing …
About
© 1995-2025